Expanding the #voluntarylicence for cabotegravir long-acting from #HIV prevention to treatment builds on 10+ years of #MPP–#ViiVHealthcare collaboration.
Founded by #Unitaid in 2010, MPP helped 23M+ access DTG—now doing the same for CAB LA with generic partners for prevention and treatment.
Founded by #Unitaid in 2010, MPP helped 23M+ access DTG—now doing the same for CAB LA with generic partners for prevention and treatment.
July 15, 2025 at 5:33 AM
Expanding the #voluntarylicence for cabotegravir long-acting from #HIV prevention to treatment builds on 10+ years of #MPP–#ViiVHealthcare collaboration.
Founded by #Unitaid in 2010, MPP helped 23M+ access DTG—now doing the same for CAB LA with generic partners for prevention and treatment.
Founded by #Unitaid in 2010, MPP helped 23M+ access DTG—now doing the same for CAB LA with generic partners for prevention and treatment.
#WorldCancerDay
At MPP, we expand access to #cancer medicines via public health–oriented licences.
In 2022, MPP signed the first-ever #voluntarylicence for a cancer medicine with @novartis.bsky.social, boosting access to nilotinib for CML with the @uiccofficial.bsky.social -led #ATOM consortium.
At MPP, we expand access to #cancer medicines via public health–oriented licences.
In 2022, MPP signed the first-ever #voluntarylicence for a cancer medicine with @novartis.bsky.social, boosting access to nilotinib for CML with the @uiccofficial.bsky.social -led #ATOM consortium.
February 4, 2026 at 3:04 PM
#WorldCancerDay
At MPP, we expand access to #cancer medicines via public health–oriented licences.
In 2022, MPP signed the first-ever #voluntarylicence for a cancer medicine with @novartis.bsky.social, boosting access to nilotinib for CML with the @uiccofficial.bsky.social -led #ATOM consortium.
At MPP, we expand access to #cancer medicines via public health–oriented licences.
In 2022, MPP signed the first-ever #voluntarylicence for a cancer medicine with @novartis.bsky.social, boosting access to nilotinib for CML with the @uiccofficial.bsky.social -led #ATOM consortium.
Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.
Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!
lnkd.in/eruiP-Gv
Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!
lnkd.in/eruiP-Gv
September 22, 2025 at 1:52 PM
Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.
Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!
lnkd.in/eruiP-Gv
Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!
lnkd.in/eruiP-Gv